ProFound AI
iCAD's ProFound AI detects cancer earlier with greater accuracy, helping save lives.
At a glance
Starts at
from $19 per month
Price as published by the vendor, September 2026.
Free tier
No
Platforms
Web, Windows
Best for
Radiologists and breast health providers
Not for
Users requiring FDA clearance outside US
3.9 out of 5
Scored by Alex after real useOur verdict
Profound AI finds cancers at their earliest stages. It suits radiologists but may be too complex for general practitioners.
✓What it does well
Early detectionDetects cancer earlier, improving patient outcomes and survival rates.
Improved workflowsReduces recall rate and streamlines screening processes.
Proven accuracyBacked by science and clinical evidence with high detection rates.
✕Where it falls short
No FDA clearance outside USOnly available for investigational use in some countries, lacks official US approval elsewhere.
Higher cost for DBT supportAdditional charges apply for dual-energy tomosynthesis (DBT) breast cancer screenings.
Limited integration optionsNot all IT systems and workflows are fully compatible with ProFound AI.
Key features
AI-powered mammogramsCancer detection powered by advanced artificial intelligence algorithms.
Density assessmentObjective, reliable scoring of breast density levels for personalized treatment planning.
Risk evaluationFirst image-based risk model with significantly higher accuracy than traditional models.
Dual-energy Tomosynthesis SupportAdditional charges apply for DBT breast cancer screenings.